Effectiveness of Radiofrequency Renal Denervation in the United States: Six-Month Primary End Point Results From the SPYRAL AFFIRM Study
Circulation: Cardiovascular Interventions · 03.11.2026
DOI: 10.1161/circinterventions.126.017422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, online erschienen am 03.11.2026. Verfasst von David E Kandzari und 18 weiteren Autor:innen. Beteiligte Einrichtung: Piedmont Heart Institute, Atlanta, GA (D.E.K.). Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Radiofrequency renal denervation (RDN) is a guideline-recommended therapy for uncontrolled hypertension. SPYRAL AFFIRM is a single-arm, postapproval study assessing the efficacy and safety of radiofrequency RDN using the Symplicity Spyral catheter. We report the 6-month primary end point results in the SPYRAL AFFIRM US population. METHODS: Enrolled patients had an office systolic/diastolic blood pressure (BP) ≥140/90 mm Hg and a home systolic BP ≥135 mm Hg. Patients with type 1 diabetes, poorly controlled type 2 diabetes (HbA1c >8.0%), or an estimated glomerular filtration rate
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Piedmont Heart Institute, Atlanta, GA (D.E.K.).
- Department of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.).
- SUNY Downstate College of Medicine, NY (M.A.W.).
- Perelman School of Medicine, University of Pennsylvania, Philadelphia (R.R.T., D.L.C.).
- University Hospital Erlangen, Germany (R.E.S.).
- HOMICAREM (HOMburg Institute for CArdioREnalMetabolic Medicine), Saarland University, Germany (M.B.).
ORCID-Profile: David E Kandzari, Kazuomi Kario, Michael A Weber, Raymond R Townsend, Michael Böhm, Kostantinos Tsioufis, Robert Stoler, Barry Bertolet, Debbie L Cohen, Te-Hsin Lung, Felix Mahfoud
Zitieren
APA
Kandzari, D. E., Kario, K., Weber, M. A., Townsend, R. R., Schmieder, R. E., Böhm, M., Tsioufis, K., Stoler, R., Lee, D. P., Navetta, F., Bertolet, B., Potluri, S., David, S., Cohen, D. L., Lung, T. H., Anderson, K., Carvelli, J., Mahfoud, F., & SPYRAL AFFIRM Study Investigators (2026). Effectiveness of Radiofrequency Renal Denervation in the United States: Six-Month Primary End Point Results From the SPYRAL AFFIRM Study. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.126.017422
Vancouver
Kandzari DE, Kario K, Weber MA, Townsend RR, Schmieder RE, Böhm M, et al. Effectiveness of Radiofrequency Renal Denervation in the United States: Six-Month Primary End Point Results From the SPYRAL AFFIRM Study. Circulation: Cardiovascular Interventions. 2026. doi:10.1161/circinterventions.126.017422
BibTeX
@article{Kandzari2026,
author = {Kandzari, David E and Kario, Kazuomi and Weber, Michael A and Townsend, Raymond R and Schmieder, Roland E and Böhm, Michael and Tsioufis, Kostantinos and Stoler, Robert and Lee, David P and Navetta, Frank and Bertolet, Barry and Potluri, Srinivasa and David, Shukri and Cohen, Debbie L and Lung, Te-Hsin and Anderson, Kelsey and Carvelli, Julie and Mahfoud, Felix and SPYRAL AFFIRM Study Investigators, SPYRAL AFFIRM Study Investigators},
title = {Effectiveness of Radiofrequency Renal Denervation in the United States: Six-Month Primary End Point Results From the SPYRAL AFFIRM Study},
journal = {Circulation: Cardiovascular Interventions},
year = {2026},
doi = {10.1161/circinterventions.126.017422}
}
EUVIMED